Galectin Therapeutics
GALT
#8191
Rank
โ‚น14.42 B
Marketcap
โ‚น229.82
Share price
-3.37%
Change (1 day)
41.41%
Change (1 year)

Galectin Therapeutics (GALT) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น2.16 Billion

According to Galectin Therapeutics's latest financial reports the company has โ‚น2.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Galectin Therapeutics - Cash on Hand chart (from 2001 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚น1.53 B-47.87%
2021-12-31โ‚น2.95 B48.67%
2020-12-31โ‚น1.98 B-41.37%
2019-12-31โ‚น3.38 B486.73%
2018-12-31โ‚น0.57 B196.03%
2017-12-31โ‚น0.19 B-81.33%
2016-12-31โ‚น1.04 B-39.22%
2015-12-31โ‚น1.71 B-6.96%
2014-12-31โ‚น1.84 B184.88%
2013-12-31โ‚น0.64 B26.39%
2012-12-31โ‚น0.51 B51.51%
2011-12-31โ‚น0.33 B28.19%
2010-12-31โ‚น0.26 B2166.59%
2009-12-31โ‚น11.64 M-23.8%
2008-12-31โ‚น15.28 M-70.47%
2007-12-31โ‚น51.76 M-79.75%
2006-12-31โ‚น0.25 B27.23%
2005-12-31โ‚น0.20 B-56.65%
2004-12-31โ‚น0.46 B33.83%
2003-12-31โ‚น0.34 B275.97%
2002-12-31โ‚น92.13 M28.05%
2001-12-31โ‚น71.95 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚น82.50 B 3,714.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น20.93 B 867.89%๐Ÿ‡บ๐Ÿ‡ธ USA